These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 22972800)
1. Mesenchymal stem cells and cardiac regeneration: a sophisticated approach depends on trophic effects--what's left over? Focus on "Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency". Zimmermann O Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1004-5. PubMed ID: 22972800 [No Abstract] [Full Text] [Related]
2. Activation of Toll-like receptor 3 amplifies mesenchymal stem cell trophic factors and enhances therapeutic potency. Mastri M; Shah Z; McLaughlin T; Greene CJ; Baum L; Suzuki G; Lee T Am J Physiol Cell Physiol; 2012 Nov; 303(10):C1021-33. PubMed ID: 22843797 [TBL] [Abstract][Full Text] [Related]
3. Pre-activation of TLR3 enhances the therapeutic effect of BMMSCs through regulation the intestinal HIF-2α signaling pathway and balance of NKB cells in experimental alcoholic liver injury. Ge L; Chen D; Chen W; Cai C; Tao Y; Ye S; Lin Z; Wang X; Li J; Xu L; Chen Y Int Immunopharmacol; 2019 May; 70():477-485. PubMed ID: 30870678 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2/6-dependent stimulation of mesenchymal stem cells promotes angiogenesis by paracrine factors. Grote K; Petri M; Liu C; Jehn P; Spalthoff S; Kokemüller H; Luchtefeld M; Tschernig T; Krettek C; Haasper C; Jagodzinski M Eur Cell Mater; 2013 Sep; 26():66-79; discussion 79. PubMed ID: 24027020 [TBL] [Abstract][Full Text] [Related]
5. Priming with Toll-like receptor 3 agonist or interferon-gamma enhances the therapeutic effects of human mesenchymal stem cells in a murine model of atopic dermatitis. Park A; Park H; Yoon J; Kang D; Kang MH; Park YY; Suh N; Yu J Stem Cell Res Ther; 2019 Feb; 10(1):66. PubMed ID: 30795812 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Zhang N; Li J; Luo R; Jiang J; Wang JA Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):104-11. PubMed ID: 18286426 [TBL] [Abstract][Full Text] [Related]
7. Post-injury regeneration in rat sciatic nerve facilitated by neurotrophic factors secreted by amniotic fluid mesenchymal stem cells. Pan HC; Cheng FC; Chen CJ; Lai SZ; Lee CW; Yang DY; Chang MH; Ho SP J Clin Neurosci; 2007 Nov; 14(11):1089-98. PubMed ID: 17954375 [TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells: future source for reparative medicine. Bhatia R; Hare JM Congest Heart Fail; 2005; 11(2):87-91; quiz 92-3. PubMed ID: 15860974 [TBL] [Abstract][Full Text] [Related]
9. Characterization of mesenchymal stem cells under the stimulation of Toll-like receptor agonists. Chen X; Zhang ZY; Zhou H; Zhou GW Dev Growth Differ; 2014 Apr; 56(3):233-44. PubMed ID: 24645700 [TBL] [Abstract][Full Text] [Related]